Triosephosphate isomerase is dispensable in vitro yet essential for Mycobacterium tuberculosis to establish infection

mBio

Volumn 5, Issue 2, 2014, Pages

  Trujillo, Carolina ^a   Blumenthal, Antje ^a,b   Marrero, Joeli ^a   Rhee, Kyu Y ^a   Schnappinger, Dirk ^a   Ehrt, Sabine ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANHYDROTETRACYCLINE; CARBON 13; HYGROMYCIN B; KANAMYCIN; STREPTOMYCIN; TRIOSEPHOSPHATE ISOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CARBON METABOLISM; CARBON SOURCE; CONTROLLED STUDY; GENE DELETION; GENE MUTATION; GLUCONEOGENESIS; GLYCOLYSIS; IN VITRO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; CARBON; CELLS, CULTURED; CULTURE MEDIA; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HOST-PATHOGEN INTERACTIONS; ISOTOPE LABELING; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; TRIOSE-PHOSPHATE ISOMERASE; TUBERCULOSIS; VIRULENCE FACTORS;

EID: 84899865913     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00085-14     Document Type: Article

References (54)

1. Wirth T, Hildebrand F, Allix-Béguec C, Wölbeling F, Kubica T, Kremer K, van Soolingen D, Rüsch-Gerdes S, Locht C, Brisse S, Meyer A, Supply P, Niemann S. 2008. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 4:e1000160. http:// dx.doi.org/10.1371/journal.ppat.1000160.
2. de Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY. 2010. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem. Biol. 17:1122-1131. http://dx.doi.org/10.1016/j.chembiol.2010.08.009.
3. Kovárová-Kovar K, Egli T. 1998. Growth kinetics of suspended microbial cells: from single-substrate-controlled growth to mixed-substrate kinetics. Microbiol. Mol. Biol. Rev. 62:646-666.
4. Görke B, Stülke J. 2008. Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat. Rev. Microbiol. 6:613-624. http://dx.doi.org/10.1038/nrmicro1932.
5. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704. http://dx.doi.org/10.1084/jem.20030846.
6. Timm J, Post FA, Bekker LG, Walther GB, Wainwright HC, Manganelli R, Chan WT, Tsenova L, Gold B, Smith I, Kaplan G, McKinney JD. 2003. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl. Acad. Sci. U. S. A. 100:14321-14326. http:// dx.doi.org/10.1073/pnas.2436197100.
7. Bloch H, Segal W. 1956. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J. Bacteriol. 72:132-141.
8. Muñoz-Elías EJ, McKinney JD. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-644. http://dx.doi.org/10.1038/nm1252.
9. Pandey AK, Sassetti CM. 2008. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. U. S. A. 105: 4376-4380. http://dx.doi.org/10.1073/pnas.0711159105.
10. Marrero J, Rhee KY, Schnappinger D, Pethe K, Ehrt S. 2010. Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc. Natl. Acad. Sci. U. S. A. 107:9819-9824. http://dx.doi.org/10.1073/pnas.1 000715107.
11. Marrero J, Trujillo C, Rhee KY, Ehrt S. 2013. Glucose phosphorylation is required for Mycobacterium tuberculosis persistence in mice. PLoS Pathog. 9:e1003116. http://dx.doi.org/10.1371/journal.ppat.1003116.
12. Phong WY, Lin W, Rao SP, Dick T, Alonso S, Pethe K. 2013. Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia. PLoS One 8:e56037. http://dx.doi.org/10.1371/journal.pone.0056037.
13. Hasan MR, Rahman M, Jaques S, Purwantini E, Daniels L. 2010. Glucose 6-phosphate accumulation in mycobacteria: implications for a novel F420-dependent anti-oxidant defense system. J. Biol. Chem. 285: 19135-19144. http://dx.doi.org/10.1074/jbc.M109.074310.
14. Wierenga RK. 2001. The TIM-barrel fold: a versatile framework for efficient enzymes. FEBS Lett. 492:193-198. http://dx.doi.org/10.1016/S0014-5793(01)02236-0.
15. Knowles JR. 1991. Enzyme catalysis: not different, just better. Nature 350:121-124. http://dx.doi.org/10.1038/350121a0.
16. Wierenga RK, Kapetaniou EG, Venkatesan R. 2010. Triosephosphate isomerase: a highly evolved biocatalyst. Cell. Mol. Life Sci. 67:3961-3982. http://dx.doi.org/10.1007/s00018-010-0473-9.
17. Fong SS, Nanchen A, Palsson BO, Sauer U. 2006. Latent pathway activation and increased pathway capacity enable Escherichia coli adaptation to loss of key metabolic enzymes. J. Biol. Chem. 281:8024-8033. http://dx.doi.org/10.1074/jbc.M510016200.
18. Desai KK, Miller BG. 2008. A metabolic bypass of the triosephosphate isomerase reaction. Biochemistry 47:7983-7985. http://dx.doi.org/10.102 1/bi801054v.
19. Zheng P, Sun J, van den Heuvel J, Zeng AP. 2006. Discovery and investigation of a new, second triose phosphate isomerase in Klebsiella pneumoniae. J. Biotechnol. 125:462-473. http://dx.doi.org/10.1016/j. jbiotec.2006.03.034.
20. Poysti NJ, Oresnik IJ. 2007. Characterization of Sinorhizobium meliloti triose phosphate isomerase genes. J. Bacteriol. 189:3445-3451. http:// dx.doi.org/10.1128/JB.01707-06.
21. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544. http://dx.doi.org/10.1038/31159.
22. Sassetti CM, Boyd DH, Rubin EJ. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48: 77-84. http://dx.doi.org/10.1046/j.1365-2958.2003.03425.x.
23. Griffin JE, Gawronski JD, Dejesus MA, Ioerger TR, Akerley BJ, Sassetti CM. 2011. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7:e1002251. http://dx.doi.org/10.1371/journal.ppat.1002251.
24. Zhang YJ, Ioerger TR, Huttenhower C, Long JE, Sassetti CM, Sacchettini JC, Rubin EJ. 2012. Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog. 8:e1002946. http://dx.doi.org/10.1371/journal.ppat.1002946.
25. Mathur D, Malik G, Garg LC. 2006. Biochemical and functional characterization of triosephosphate isomerase from Mycobacterium tuberculosis H37Rv. FEMS Microbiol. Lett. 263:229-235. http://dx.doi.org/10.1111/j. 1574-6968.2006.00420.x.
26. Connor SE, Capodagli GC, Deaton MK, Pegan SD. 2011. Structural and functional characterization of Mycobacterium tuberculosis triosephosphate isomerase. Acta Crystallogr. D Biol. Crystallogr. 67:1017-1022. http://dx.doi.org/10.1107/S0907444911042971.
27. Ehrt S, Guo XV, Hickey CM, Ryou M, Monteleone M, Riley LW, Schnappinger D. 2005. Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res. 33:e21. http:// dx.doi.org/10.1093/nar/gni013.
28. Klotzsche M, Ehrt S, Schnappinger D. 2009. Improved tetracycline repressors for gene silencing in mycobacteria. Nucleic Acids Res. 37: 1778-1788. http://dx.doi.org/10.1093/nar/gkp015.
29. Grüning NM, Rinnerthaler M, Bluemlein K, Mülleder M, Wamelink MM, Lehrach H, Jakobs C, Breitenbach M, Ralser M. 2011. Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells. Cell Metab. 14:415-427. http://dx.doi.org/10.1016/j. cmet.2011.06.017.
30. Cooper RA, Anderson A. 1970. The formation and catabolism of methylglyoxal during glycolysis in Escherichia coli. FEBS Lett. 11:273-276. http://dx.doi.org/10.1016/0014-5793(70)80546-4.
31. Inoue Y, Kimura A. 1995. Methylglyoxal and regulation of its metabolism in microorganisms. Adv. Microb. Physiol. 37:177-227. http://dx.doi.org/ 10.1016/S0065-2911(08)60146-0.
32. Ferguson GP, Tötemeyer S, MacLean MJ, Booth IR. 1998. Methylglyoxal production in bacteria: suicide or survival? Arch. Microbiol. 170: 209-218. http://dx.doi.org/10.1007/s002030050635.
33. Booth IR, Ferguson GP, Miller S, Li C, Gunasekera B, Kinghorn S. 2003. Bacterial production of methylglyoxal: a survival strategy or death by misadventure? Biochem. Soc. Trans. 31:1406-1408. http://dx.doi.org/ 10.1042/BST0311406.
34. Pethe K, Sequeira PC, Agarwalla S, Rhee K, Kuhen K, Phong WY, Patel V, Beer D, Walker JR, Duraiswamy J, Jiricek J, Keller TH, Chatterjee A, Tan MP, Ujjini M, Rao SPS, Camacho L, Bifani P, Mak PA, Ma I, Barnes SW, Chen Z, Plouffe D, Thayalan P, Ng SH, Au M, Lee BH, Tan BH, Ravindran S, Nanjundappa M, Lin X, Goh A, Lakshminarayana SB, Shoen C, Cynamon M, Kreiswirth B, Dartois V, Peters EC, Glynne R, Brenner S, Dick T. 2010. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat. Commun. 1:1-8. http://dx.doi.org/10.1038 /ncomms1008.
35. Berney M, Weimar MR, Heikal A, Cook GM. 2012. Regulation of proline metabolism in mycobacteria and its role in carbon metabolism under hypoxia. Mol. Microbiol. 84:664-681. http://dx.doi.org/10.1111/j. 1365-2958.2012.08053.x.
36. McKinney JD, zu Bentrup K, Muñoz-Elías EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs WR, Russell DG. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738. http:// dx.doi.org/10.1038/35021074.
37. Anderson A, Cooper RA. 1969. Gluconeogenesis in Escherichia coli. The role of triose phosphate isomerase. FEBS Lett. 4:19-20. http://dx.doi.org/ 10.1016/0014-5793(69)80184-5.
38. Paterson GK, Cone DB, Northen H, Peters SE, Maskell DJ. 2009. Deletion of the gene encoding the glycolytic enzyme triosephosphate isomerase (tpi) alters morphology of Salmonella enterica serovar Typhimurium and decreases fitness in mice. FEMS Microbiol. Lett. 294:45-51. http://dx.doi.org/10.1111/j.1574-6968.2009.01553.x.
39. Eisenberg RC, Dobrogosz WJ. 1967. Gluconate metabolism in Escherichia coli. J. Bacteriol. 93:941-949.
40. Portais JC, Tavernier P, Gosselin I, Barbotin JN. 1999. Cyclic organization of the carbohydrate metabolism in Sinorhizobium meliloti. Eur. J. Biochem. 265:473-480. http://dx.doi.org/10.1046/j.1432-1327.1999.0077 8.x.
41. Portais JC, Tavernier P, Gosselin I, Barbotin JN. 2000. Relevance and isotopic assessment of hexose-6-phosphate recycling in micro-organisms. J. Biotechnol. 77:49-64. http://dx.doi.org/10.1016/S0168-1656(99)00207-2.
42. Gosselin I, Wattraint O, Riboul D, Barbotin J, Portais J. 2001. A deeper investigation on carbohydrate cycling in Sinorhizobium meliloti. FEBS Lett. 499:45-49. http://dx.doi.org/10.1016/S0014-5793(01)02518-2.
43. Beste DJV, Bonde B, Hawkins N, Ward JL, Beale MH, Noack S, Nöh K, Kruger NJ, Ratcliffe RG, McFadden J. 2011. C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation. PLoS Pathog. 7:e1002091. http://dx.doi.org/10.1371/journal.ppat.1002091.
44. Beste DJ, Nöh K, Niedenführ S, Mendum TA, Hawkins ND, Ward JL, Beale MH, Wiechert W, McFadden J. 2013. 13C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis. Chem. Biol. 20:1-10. http://dx.doi.org/10.1016/j. chembiol.2013.01.008.
45. Henderson B, Martin A. 2011. Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease. Infect. Immun. 79:3476-3491. http://dx.doi.org/10. 1128/IAI.00179-11.
46. Maithal K, Ravindra G, Balaram H, Balaram P. 2002. Inhibition of Plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine. Electrospray ionization mass spectrometric analysis of differential cysteine reactivities. J. Biol. Chem. 277: 25106-25114. http://dx.doi.org/10.1074/jbc.M202419200.
47. Téllez-Valencia A, Olivares-Illana V, Hernández-Santoyo A, Pérez-Montfort R, Costas M, Rodríguez-Romero A, López-Calahorra F, Tuena De Gómez-Puyou M, Gómez-Puyou A. 2004. Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface. J. Mol. Biol. 341:1355-1365. http://dx.doi.org/10.1016/j. jmb.2004.06.056.
48. Hernández-Alcántara G, Torres-Larios A, Enríquez-Flores S, García-Torres I, Castillo-Villanueva A, Méndez ST, de la Mora-de la Mora I, Gómez-Manzo S, Torres-Arroyo A, López-Velázquez G, Reyes-Vivas H, Oria-Hernández J. 2013. Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region. PLoS One 8:e69031. http://dx.doi.org/10.1371 /journal.pone.0069031.
49. Romo-Mancillas A, Téllez-Valencia A, Yépez-Mulia L, Hernández-Luis F, Hernández-Campos A, Castillo R. 2011. The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: a problem of residue motility. J. Mol. Graph. Model. 30:90-99. http://dx.doi.org/10.1016/j.jmgm.2011.06.009.
50. Allen BW. 1998. Mycobacteria: general culture methodology and safety considerations. Methods Mol. Biol. 101:15-30.
51. Gracy RW. 1975. Triosephosphate isomerase from human erythrocytes. Methods Enzymol. 41:442-447. http://dx.doi.org/10.1016/S0076-6879(7 5)41096-5.
52. Eoh H, Rhee KY. 2013. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 110:6554-6559. http://dx.doi.org/10.1073/pnas.12193 75110.
53. Randell EW, Vasdev S, Gill V. 2005. Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. J. Pharmacol. Toxicol. Methods 51:153-157. http:// dx.doi.org/10.1016/j.vascn.2004.08.005.
54. Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S. 2008. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat. Med. 14:849-854. http://dx.doi.org/10.1038 /nm.1795.